Geoffrey Liu - Business-News-Today.com

🚀 Building a website? Start with reliable WordPress hosting from MilesWeb →

Business news, market intelligence, and global industry analysis.

The Latest

Baltic Classifieds Group (LSE: BCG) rebounds after FY26 sell-off as buyback-fuelled debt swing tests the Baltic monopoly thesis

India charges Hafiz Saeed over Pahalgam attack as Pakistan accountability test deepens

Russia attacks Kyiv with 68 missiles and 351 drones as Patriot stocks run low

Ocado Group (LSE: OCDO) sets 2028 handover date for founder CEO Tim Steiner as board formalises succession runway

Representative image of a laboratory research setting used to illustrate Nuvalent’s AACR 2026 zidesamtinib update in ROS1-positive non-small cell lung cancer, including focus on brain penetration, resistance mutations, and next-line treatment potential.

Read More

Pharma Industry News

Nuvalent (NASDAQ: NUVL) sharpens zidesamtinib case at AACR 2026 with post-TKI ROS1 lung cancer data

Nuvalent’s AACR 2026 zidesamtinib data could reshape the ROS1 NSCLC treatment debate ahead of its FDA decision. Read what it means now.

April 19, 2026

web analytics